$162.44
0.70% yesterday
NYSE, Nov 25, 10:10 pm CET
ISIN
US74834L1008
Symbol
DGX

Quest Diagnostics Stock price

$162.44
+7.40 4.77% 1M
+21.16 14.98% 6M
+24.56 17.81% YTD
+27.13 20.05% 1Y
+12.92 8.64% 3Y
+55.91 52.48% 5Y
+98.62 154.53% 10Y
NYSE, Closing price Mon, Nov 25 2024
-1.15 0.70%
ISIN
US74834L1008
Symbol
DGX
Sector

Key metrics

Market capitalization $18.13b
Enterprise Value $24.45b
P/E (TTM) P/E ratio 21.81
EV/FCF (TTM) EV/FCF 23.90
EV/Sales (TTM) EV/Sales 2.56
P/S ratio (TTM) P/S ratio 1.90
P/B ratio (TTM) P/B ratio 2.67
Dividend yield 1.85%
Last dividend (FY24) $3.00
Revenue growth (TTM) Revenue growth 2.60%
Revenue (TTM) Revenue $9.54b
EBIT (operating result TTM) EBIT $1.35b
Free Cash Flow (TTM) Free Cash Flow $1.02b
Cash position $764.00m
EPS (TTM) EPS $7.45
P/E forward 21.06
P/S forward 1.84
EV/Sales forward 2.49
Short interest 2.44%
Show more

Is Quest Diagnostics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Quest Diagnostics Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Quest Diagnostics forecast:

10x Buy
50%
10x Hold
50%

Analyst Opinions

20 Analysts have issued a Quest Diagnostics forecast:

Buy
50%
Hold
50%

Financial data from Quest Diagnostics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
9,539 9,539
3% 3%
100%
- Direct Costs 6,511 6,511
3% 3%
68%
3,028 3,028
1% 1%
32%
- Selling and Administrative Expenses 1,211 1,211
1% 1%
13%
- Research and Development Expense - -
-
-
1,817 1,817
1% 1%
19%
- Depreciation and Amortization 467 467
5% 5%
5%
EBIT (Operating Income) EBIT 1,350 1,350
0% 0%
14%
Net Profit 838 838
10% 10%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Quest Diagnostics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quest Diagnostics Stock News

Positive
Market Watch
about 21 hours ago
Other companies whose consensus 2025 revenue estimates have increased the most include BlackRock and Coterra Energy.
Neutral
Business Wire
11 days ago
VANCOUVER, British Columbia--(BUSINESS WIRE)-- #AxialSpondyloarthritis--Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusive agreement with Quest Diagnostics, a leading provider of diagnostic information services, under which Quest will validate and offer a lab-developed test based on the Augurex 14-3-3η (eta) biomark...
Neutral
PRNewsWire
14 days ago
SECAUCUS, N.J. , Nov. 12, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.75 per share, payable on January 29, 2025 to shareholders of record of Quest Diagnostics common stock on January 14, 2025.
More Quest Diagnostics News

Company Profile

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Head office United States
CEO James Davis
Employees 48,000
Founded 1967
Website www.questdiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today